The pharmaceutical industry is attempting to convince the public that a variety of normal conditions affecting the majority of women should be classified as “female sexual dysfunction” and treated with drugs.
The pharmaceutical industry is attempting to convince the public that a variety of normal conditions affecting the majority of women should be classified as “female sexual dysfunction” and treated with drugs.